Authors
Latest:
Show Me the Value: Tomorrow's Care for Today's PatientsThe shift from a fee-for-service to a fee-for-value model in pharmacy means an increased emphasis on clinical outcomes.
Latest:
Hybrid Models Can Transform Team ChemistryMorristown Medical Center’s area-based pharmacist program leads to an increase in direct patient contact and opportunities for interventions.
Latest:
PARP Inhibitors: A Novel Approach to Treating Ovarian CancerPARP inhibitors are novel therapies with indication focused on ovarian cancer; however, new agents are being studied for other cancers as well.
Latest:
How Pharma Can Strike the Right Balance Between Control and Flexibility in IT Quality SystemsPharma companies struggle to find the right balance between rigid quality systems and risk-based flexible quality systems.
Latest:
New Rules on Mandatory COVID-19 Vaccinations: Applicability to PharmaciesCMS Interim Final Rule on mandatory COVID-19 vaccinations for all facilities participating in Medicare and Medicaid potentially impacts pharmacies that provide services under a contract or arrangement with these facilities.
Latest:
Value-Based Benefit Design and Healthcare Utilization in Asthma, Hypertension, and DiabetesA value-based benefit design program for prescription medications for asthma, hypertension, and diabetes could result in increased prescription use and decreased healthcare utilization and costs.
Latest:
Bipolar Disorder: Treating Both Ends of the SpectrumAt the time of writing, Dr. Striker was a psychiatry pharmacy resident at the Louis Stokes Cleveland Department of Veterans Affairs Medical Center (VAMC), a pharmacist at Huron Hospital, and a relief pharmacist with Target Pharmacy. Dr. Fuller is a clinical pharmacy specialist in psychiatry at the Louis Stokes Cleveland VAMC, a clinical pharmacy specialist in psychiatry with Lexi-Comp Inc, an associate clinical professor of psychiatry at Case Western Reserve University, and an adjunct associate professor of clinical pharmacy at the University of Toledo.
Latest:
AstraZeneca's BrilintaThe FDA approved Brilinta (ticagrelor) for reducing the rate of thrombotic cardiovascular events in patients with acute coronary syndrome when taken with aspirin.
Latest:
Interning with the United States PharmacopeiaTo truly become the best versions of ourselves, it is important to constantly seek challenges that expand our personal limits and horizons.
Latest:
CDC Makes Recommendations for Preserving Brain HealthFew drugs are available to address cognitive decline, but dietary changes, mental and physical activity, and social engagement can all help.
Latest:
Patient-Centered Care: Warfarin Nonadherence in Patients with Mental Health ConditionsThe influence of mental illness on adherence among patients who should be taking warfarin is not well understood.
Latest:
Drug Utilization Patterns in Patients With Alzheimer's DiseaseThe proportion of Americans diagnosed with Alzheimer's disease (AD) is projected to increase almost 2-fold over the next couple of decades due to size of the Baby Boom generation compared with the total US population.
Latest:
Handling Professional Ghosting in PharmacyIf you are either seeking employment or want to move forward with your career, understanding the consequences of professional ghosting is a must in 2020.
Latest:
Specialty Pharmacy Data Standards in a Rapidly Evolving Value-Based WorldSpecialty medications also are the fastest growing cost component of total health care costs.
Latest:
Fosfomycin UseFosfomycin (Monurol) is an antibiotic that uses a unique mechanism of action to establish its bactericidal activity.
Latest:
340B Oversight: Interdisciplinary Approach Ensures Continuous ComplianceThe 340B drug pricing program was enacted in 1992.
Latest:
Evaluation of Therapeutic Interchange From Donepezil to Galantamine Extended-ReleaseTherapeutic interchange from donepezil to galantamine extended-release: a 3-month analysis.
Latest:
Specialty Pharmacy and Health Care ReformHealth care reform and the increasing pipeline of specialty have created a "perfect storm" of significant business and financial impacts to patients, insurers, health care providers, manufacturers, and pharmacies.
Latest:
Medicare Part D Optimization: Potential Out-of-Pocket Savings Through Plan ReexaminationMedicare Part D plans can change their cost-sharing structure and formularies every year. As such, beneficiaries should annually reevaluate plan offerings to minimize their out-of-pocket costs.
Latest:
An Externship in Public HealthIn recent years, career options for pharmacists have grown beyond the traditional settings of retail drugstores and hospitals.
Latest:
Evaluation of Dual Versus Triple Therapy for Hepatitis CIn this retrospective chart review, patients with hepatitis C had a sustained virologic response with either dual or triple therapy.
Latest:
Findings Related to Assessing Value for Private US Health PlansA qualitative survey and quantitative database analysis of US payers indicated that determining whether they receive value for their expenditures involves substantial challenges.
Latest:
Predictors of Healthcare Costs After Initiating Dabigatran Versus WarfarinThe study found no mean difference in all-cause healthcare costs for patients with newly diagnosed nonvalvular atrial fibrillation initiating treatment with dabigatran versus warfarin.
Latest:
Medication Therapy Management and Health Care ReformThe changes that the Affordable Care Act has brought to the practice of pharmacy may not be well known.
Latest:
Tips for Managing Adverse Drug ReactionsFear of adverse drug events often influences adherence decisions.
Latest:
High Expectations Accompany Specialty Drug TherapiesClinical outcomes have different meanings among specialty pharmacy stakeholders.
Latest:
The Importance of Provider Status for PharmacistsThroughout the pandemic, pharmacists have played a critical role in the COVID-19 response in several ways
Latest:
Treating COVID-19 or Rheumatoid Arthritis? Exploring Proposed Drug Therapy, Safety ConcernsWhat characteristics of RA treatments possibly connect to COVID-19 treatment?
